Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05986305 · ClinicalTrials.gov registry record · NA
Improving the Health of Parents and Their Adolescent and Transition-age Youth With Intellectual and Developmental Disabilities
A NA study of Intellectual Disability, sponsored by University of North Carolina, Chapel Hill.
- Active
- Registry status
- NA
- Development phase
- 406
- Enrollment target
- 2
- Study locations
NCT05986305: Active NA study of Intellectual Disability, sponsored by University of North Carolina, Chapel Hill.
NCT05986305 is a NA study of Intellectual Disability that is active but no longer recruiting, run by University of North Carolina, Chapel Hill. The registered enrollment target is 406 participants, above the 338-participant average among 26 other Intellectual Disability trials with a reported enrollment target (20% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05986305, a NA study of Intellectual Disability, is active but no longer recruiting, sponsored by University of North Carolina, Chapel Hill.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 406 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will determine the comparative effectiveness of Go Act, a tailored advocacy curriculum versus Peer parent-directed peer learning for increasing parent activation for parents of youth with intellectual and developmental disabilities. Second, it will determine the comparative effectiveness of the two study arms for improving parent and youth health outcomes while assessing whether parent activation serves as a mechanism that mediates their effects on health outcomes.
Primary Outcome
The Parent Patient Activation Measure will be used to capture parent activation on behalf of their child (mean score=70) at 6, 12 and 18 months after intervention. The Parent Patient Activation Measure is a parent self-report 13-item scale with 4-level likert responses and scores ranging from 0 to 100.
Conditions Studied
Interventions
- BEHAVIORAL Go Act
- BEHAVIORAL Peer
Study Locations (2)
North Carolina
- The Carolina Institute for Developmental Disabilities - Carrboro
- UNC Adult Psychiatry Clinic - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What the registry record for NCT05986305 still lists
NCT05986305 is an interventional study that assigns participants to a tested intervention. The registered 406 participants enrollment target is mid-sized for trials with a published cap, above the 338-participant average among 26 other Intellectual Disability trials with a reported enrollment target (20% higher).
The record links to 1 condition, with Intellectual Disability appearing as the primary indexed condition, and to 2 interventions - of which Go Act is the first listed.
NCT05986305 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05986305 about?
NCT05986305 is a clinical study titled "Improving the Health of Parents and Their Adolescent and Transition-age Youth With Intellectual and Developmental Disabilities". This study will determine the comparative effectiveness of Go Act, a tailored advocacy curriculum versus Peer parent-directed peer learning for increasing parent activation for parents of youth with intellectual and developmental disabilities. Second, it will determine the comparative effectiveness ...
What is the current status of trial NCT05986305?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 406 participants. The study started on 2023-08-08. Estimated completion is 2026-05-31.
What conditions does trial NCT05986305 study?
This clinical trial studies the following conditions: Intellectual Disability.
What interventions are being tested in trial NCT05986305?
The interventions under investigation include: Go Act (BEHAVIORAL), Peer (BEHAVIORAL).
Who is sponsoring clinical trial NCT05986305?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05986305 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intellectual Disability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05986305's enrollment target sits among peer trials
406 5th of 26 higher than 22 of 26 other Intellectual Disability trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Intellectual Disability trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth
RECRUITING · NA
-
Online Learning Module to Advance Research Related to People With Disabilities
RECRUITING · NA
-
Future Planning and Well-Being for Individuals With Intellectual Disabilities and Family Caregivers
RECRUITING · NA
-
Harnessing Communication Preferences
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
- NCT06585787 · 406 participants · Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI